Iris disorder

disease
On this page

Also known as disease of irisdisease or disorder of irisdisorder of irisiris diseaseiris disease or disorder

Summary

Iris disorder (MONDO:0002289) is a disease (an umbrella term covering 8 Mondo subtypes) with 2 GWAS associations across 5 studies and 3 clinical trials. A subtype of uveal disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

  • Umbrella term: 8 Mondo subtypes
  • GWAS associations: 2
  • Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

FieldValue
Canonical nameiris disorder
Mondo IDMONDO:0002289
MeSHD007499
DOIDDOID:240
NCITC34737
SNOMED CT85478004
UMLSC0022078
MedGen9556
Anatomy (UBERON)UBERON:0001769
Is cancer (heuristic)no

Also known as: disease of iris · disease or disorder of iris · disorder of iris · iris disease · iris disease or disorder · iris disorder

Data availability: 2 GWAS associations (5 studies).

Disease family

This is a subtype of uveal disorder. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › disorder of orbital regioneye disorderuveal disorderiris disorder

Related subtypes (3): optic choroid disorder, uveitis, uvea neoplasm

Subtypes (8): pupil disorder, ciliary body disorder, iritis, exfoliation syndrome, aniridia, iris neoplasm, anterior segment dysgenesis 3, intraoperative floppy iris syndrome

Genetics & variants

GWAS landscape

2 GWAS associations across 5 studies. Top hits map to 1 distinct genes (as reported by GWAS).

Top associations by p-value

rsIDp-valueGeneRisk alleleOdds ratio
rs10426022e-12TYRC0.15

Top studies (by case count)

StudyLead authorYearCasesControlsTitle
GCST90475899Verma A20244,472441,070Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program.
GCST90477786Verma A20241,118119,290Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program.
GCST90480100Verma A20241,118119,290Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program.
GCST90481942Verma A202446358,885Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program.
GCST90436026Zhou W2018405401,245Efficiently controlling for case-control imbalance and sample relatedness in large-scale genetic association studies.

Variant details and genetic-evidence tiers

Tier distribution (top 50 variants)

TierVariants
Tier 1: coding1
Tier 2: splice/UTR0
Tier 3: regulatory0
Tier 4: intronic/intergenic0

MAF distribution

BucketVariants
common (>=0.05)1
low_freq (0.01-0.05)0
rare (<0.01)0
unknown0

Functional consequences

ConsequenceCount
missense_variant1

Top variants

rsIDChrPosAllelesMAFConsequenceGenep-valueTier
rs10426021189178528C>A0.371missense_variantTYR2e-12Tier 1: coding

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

PhaseTrials
Not specified3

Top trials by phase / activity

NCTPhaseStatusTitle
NCT04011878Not specifiedCOMPLETEDHistopathological Examination of Iris Tissue in Buphthalmos
NCT05759715Not specifiedCOMPLETEDIris Color and Day-Night Changes in the Sympathovagal Ratio
NCT07034651Not specifiedCOMPLETEDElectron Microscopic Examination of Iris Tissue in Buphthalmos

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.